Cell Growth & Differentiation, Vol 9, Issue 1 79-84, Copyright © 1998 by American Association of Cancer Research

ARTICLES

mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway

YC Chang, YS Lee, T Tejima, K Tanaka, S Omura, NH Heintz, Y Mitsui and J Magae
National Institute of Bioscience and Human-Technology, Tsukuba, Japan.

Upon activation in response to cellular stress or DNA damage, the p53 tumor suppressor induces the expression of gene products involved in cell cycle arrest and apoptosis. Using the proteasome-specific inhibitors, MG132 (N-acetyl-L-leucinyl-L-leucinal-L-leucinal) and lactacystin, here we show that the p53-response proteins, bax and mdm2 as well as p21, are degraded by the ubiquitin-proteasome pathway in HeLa cells. MG132 also increased expression of the three proteins in cells that lack p53, showing that stabilization of the p53 response proteins is not due to increased levels of p53 itself. Increases in mdm2 protein levels by MG132 was accompanied by increases in polyubiquitinated forms of the proteins. Our results indicate that ubiquitin-dependent protein degradation influences the turnover of downstream targets of p53, therefore suggesting that the proteasome plays a role in regulating apoptosis and cell cycle arrest in response to p53.

This article has been cited by other articles:

				F.-T. Liu, S. G. Agrawal, J. G. Gribben, H. Ye, M.-Q. Du, A. C. Newland, and L. Jia Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL Blood, March 1, 2008; 111(5): 2797 - 2805. [Abstract] [Full Text] [PDF]

				S. G. Agrawal, F.-T. Liu, C. Wiseman, S. Shirali, H. Liu, D. Lillington, M.-Q. Du, D. Syndercombe-Court, A. C. Newland, J. G. Gribben, et al. Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia Blood, March 1, 2008; 111(5): 2790 - 2796. [Abstract] [Full Text] [PDF]

				F. Zhang, A. J. Paterson, P. Huang, K. Wang, and J. E. Kudlow Metabolic Control of Proteasome Function Physiology, December 1, 2007; 22(6): 373 - 379. [Abstract] [Full Text] [PDF]

				T.-H. Cheng and S. N. Cohen Human MDM2 Isoforms Translated Differentially on Constitutive versus p53-Regulated Transcripts Have Distinct Functions in the p53/MDM2 and TSG101/MDM2 Feedback Control Loops Mol. Cell. Biol., January 1, 2007; 27(1): 111 - 119. [Abstract] [Full Text] [PDF]

				D. Chen, Q. C. Cui, H. Yang, and Q. P. Dou Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity Cancer Res., November 1, 2006; 66(21): 10425 - 10433. [Abstract] [Full Text] [PDF]

				S. R. Powell The ubiquitin-proteasome system in cardiac physiology and pathology Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H1 - H19. [Abstract] [Full Text] [PDF]

				E. A. Obeng, L. M. Carlson, D. M. Gutman, W. J. Harrington Jr, K. P. Lee, and L. H. Boise Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells Blood, June 15, 2006; 107(12): 4907 - 4916. [Abstract] [Full Text] [PDF]

				H. Servais, Y. Jossin, F. Van Bambeke, P. M. Tulkens, and M.-P. Mingeot-Leclercq Gentamicin Causes Apoptosis at Low Concentrations in Renal LLC-PK1 Cells Subjected to Electroporation. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1213 - 1221. [Abstract] [Full Text] [PDF]

				G. Dasmahapatra, M. Rahmani, P. Dent, and S. Grant The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism Blood, January 1, 2006; 107(1): 232 - 240. [Abstract] [Full Text] [PDF]

				J. Huang, T. Tatsumi, E. Pizzoferrato, N. Vujanovic, and W. J. Storkus Nitric Oxide Sensitizes Tumor Cells to Dendritic Cell-Mediated Apoptosis, Uptake, and Cross-Presentation Cancer Res., September 15, 2005; 65(18): 8461 - 8470. [Abstract] [Full Text] [PDF]

				M. Pervan, K. S. Iwamoto, and W. H. McBride Proteasome Structures Affected by Ionizing Radiation Mol. Cancer Res., July 1, 2005; 3(7): 381 - 390. [Abstract] [Full Text] [PDF]

				S. S. Magal, A. Jackman, S. Ish-Shalom, L. E. Botzer, P. Gonen, R. Schlegel, and L. Sherman Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16 J. Gen. Virol., March 1, 2005; 86(3): 611 - 621. [Abstract] [Full Text] [PDF]

				W.-J. Chen and J.-K. Lin Induction of G1 Arrest and Apoptosis in Human Jurkat T Cells by Pentagalloylglucose through Inhibiting Proteasome Activity and Elevating p27Kip1, p21Cip1/WAF1, and Bax Proteins J. Biol. Chem., April 2, 2004; 279(14): 13496 - 13505. [Abstract] [Full Text] [PDF]

				Y.-H. Ling, L. Liebes, J.-D. Jiang, J. F. Holland, P. J. Elliott, J. Adams, F. M. Muggia, and R. Perez-Soler Mechanisms of Proteasome Inhibitor PS-341-induced G2-M-Phase Arrest and Apoptosis in Human Non-Small Cell Lung Cancer Cell Lines Clin. Cancer Res., March 1, 2003; 9(3): 1145 - 1154. [Abstract] [Full Text] [PDF]

				A. Gewies and S. Grimm UBP41 Is a Proapoptotic Ubiquitin-specific Protease Cancer Res., February 1, 2003; 63(3): 682 - 688. [Abstract] [Full Text] [PDF]

				F. Ravandi, M. Talpaz, and Z. Estrov Modulation of Cellular Signaling Pathways: Prospects for Targeted Therapy in Hematological Malignancies Clin. Cancer Res., February 1, 2003; 9(2): 535 - 550. [Abstract] [Full Text] [PDF]

				Z. Lai, T. Yang, Y. B. Kim, T. M. Sielecki, M. A. Diamond, P. Strack, M. Rolfe, M. Caligiuri, P. A. Benfield, K. R. Auger, et al. Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors PNAS, November 12, 2002; 99(23): 14734 - 14739. [Abstract] [Full Text] [PDF]

				F. Blanchard, Y. Wang, E. Kinzie, L. Duplomb, A. Godard, and H. Baumann Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor alpha , and Oncostatin M Receptor beta by Distinct Mechanisms J. Biol. Chem., December 7, 2001; 276(50): 47038 - 47045. [Abstract] [Full Text] [PDF]

				W. J. Montigny, C. R. Houchens, S. Illenye, J. Gilbert, E. Coonrod, Y.-C. Chang, and N. H. Heintz Condensation by DNA looping facilitates transfer of large DNA molecules into mammalian cells Nucleic Acids Res., May 1, 2001; 29(9): 1982 - 1988. [Abstract] [Full Text] [PDF]

				Y. Tanaka, S. Engelender, S. Igarashi, R. K. Rao, T. Wanner, R. E. Tanzi, A. Sawa, V. L. Dawson, T. M. Dawson, and C. A. Ross Inducible expression of mutant {{alpha}}-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis Hum. Mol. Genet., April 1, 2001; 10(9): 919 - 926. [Abstract] [Full Text] [PDF]

				A. Seluanov, V. Gorbunova, A. Falcovitz, A. Sigal, M. Milyavsky, I. Zurer, G. Shohat, N. Goldfinger, and V. Rotter Change of the Death Pathway in Senescent Human Fibroblasts in Response to DNA Damage Is Caused by an Inability To Stabilize p53 Mol. Cell. Biol., March 1, 2001; 21(5): 1552 - 1564. [Abstract] [Full Text]

				J. S. Foster, D. C. Henley, A. Bukovsky, P. Seth, and J. Wimalasena Multifaceted Regulation of Cell Cycle Progression by Estrogen: Regulation of Cdk Inhibitors and Cdc25A Independent of Cyclin D1-Cdk4 Function Mol. Cell. Biol., February 1, 2001; 21(3): 794 - 810. [Abstract] [Full Text]

				M. V. BLAGOSKLONNY p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect FASEB J, October 1, 2000; 14(13): 1901 - 1907. [Abstract] [Full Text]

				C. Chen, H. Lin, C. Karanes, G. R. Pettit, and B. D. Chen Human THP-1 Monocytic Leukemic Cells Induced to Undergo Monocytic Differentiation by Bryostatin 1 Are Refractory to Proteasome Inhibitor-induced Apoptosis Cancer Res., August 1, 2000; 60(16): 4377 - 4385. [Abstract] [Full Text]

				F. Chen, D. Chang, M. Goh, S. A. Klibanov, and M. Ljungman Role of p53 in Cell Cycle Regulation and Apoptosis following Exposure to Proteasome Inhibitors Cell Growth Differ., May 1, 2000; 11(5): 239 - 246. [Abstract] [Full Text]

				F. Moretti, S. Nanni, A. Farsetti, M. Narducci, M. Crescenzi, S. Giuliacci, A. Sacchi, and A. Pontecorvi Effects of Exogenous p53 Transduction in Thyroid Tumor Cells with Different p53 Status J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 302 - 308. [Abstract] [Full Text]

				H. C. A. DREXLER, W. RISAU, and M. A. KONERDING Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells FASEB J, January 1, 2000; 14(1): 65 - 77. [Abstract] [Full Text]

				J. H. Qiu, A. Asai, S. Chi, N. Saito, H. Hamada, and T. Kirino Proteasome Inhibitors Induce Cytochrome c-Caspase-3-Like Protease-Mediated Apoptosis in Cultured Cortical Neurons J. Neurosci., January 1, 2000; 20(1): 259 - 265. [Abstract] [Full Text] [PDF]

				D. A. Sharp, S. A. Kratowicz, M. J. Sank, and D. L. George Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein J. Biol. Chem., December 31, 1999; 274(53): 38189 - 38196. [Abstract] [Full Text] [PDF]

				K. D. Wilkinson Ubiquitin-Dependent Signaling: The Role of Ubiquitination in the Response of Cells to Their Environment. J. Nutr., November 1, 1999; 129(11): 1933 - 1936. [Abstract] [Full Text]

				A. Zaika, N. Marchenko, and U. M. Moll Cytoplasmically "Sequestered" Wild Type p53 Protein Is Resistant to Mdm2-mediated Degradation J. Biol. Chem., September 24, 1999; 274(39): 27474 - 27480. [Abstract] [Full Text] [PDF]

				S. Glockzin, A. von Knethen, M. Scheffner, and B. Brune Activation of the Cell Death Program by Nitric Oxide Involves Inhibition of the Proteasome J. Biol. Chem., July 9, 1999; 274(28): 19581 - 19586. [Abstract] [Full Text] [PDF]

				Y. Pan and D. S. Haines The Pathway Regulating MDM2 Protein Degradation Can Be Altered in Human Leukemic Cells Cancer Res., May 1, 1999; 59(9): 2064 - 2067. [Abstract] [Full Text] [PDF]

				M. H. G. Kubbutat, R. L. Ludwig, A. J. Levine, and K. H. Vousden Analysis of the Degradation Function of Mdm2 Cell Growth Differ., February 1, 1999; 10(2): 87 - 92. [Abstract] [Full Text]

				K. Breitschopf, A. M. Zeiher, and S. Dimmeler Ubiquitin-mediated Degradation of the Proapoptotic Active Form of Bid. A FUNCTIONAL CONSEQUENCE ON APOPTOSIS INDUCTION J. Biol. Chem., July 7, 2000; 275(28): 21648 - 21652. [Abstract] [Full Text] [PDF]

				M. V. Chernov, L. J. H. Bean, N. Lerner, and G. R. Stark Regulation of Ubiquitination and Degradation of p53 in Unstressed Cells through C-terminal Phosphorylation J. Biol. Chem., August 17, 2001; 276(34): 31819 - 31824. [Abstract] [Full Text] [PDF]

				B. Li and Q. P. Dou Bax degradation by the ubiquitin/proteasome-dependent pathway: Involvement in tumor survival and progression PNAS, April 11, 2000; 97(8): 3850 - 3855. [Abstract] [Full Text] [PDF]

				R. Lev Bar-Or, R. Maya, L. A. Segel, U. Alon, A. J. Levine, and M. Oren Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study PNAS, October 10, 2000; 97(21): 11250 - 11255. [Abstract] [Full Text] [PDF]